ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 | Cancer-related genes CD markers Predicted membrane proteins
| | | | ![](/images/54719/135303_A_3_8_rna_selected_60x60.jpg) | Tissue enhanced |
ADD2 | Adducin 2 (beta) | Cytoskeleton related proteins
| | ![](/images_static/na_center.gif) | | ![](/images/9796/24747_B_1_7_rna_selected_60x60.jpg) | Group enriched |
AHNAK2 | AHNAK nucleoprotein 2 | Cancer-related genes
| | | | ![](/images/20111/47158_B_9_5_rna_selected_60x60.jpg) | Tissue enriched |
AHSG | Alpha-2-HS-glycoprotein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/1524/4371_B_7_3_rna_selected_60x60.jpg) | Tissue enriched |
AK4 | Adenylate kinase 4 | Enzymes Mitochondrial proteins Predicted secreted proteins
| | | | ![](/images/42753/94807_A_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
AKR1B1 | Aldo-keto reductase family 1, member B1 (aldose reductase) | Cancer-related genes Enzymes Plasma proteins
| | | | ![](/images/18773/40837_B_7_4_rna_selected_60x60.jpg) | Tissue enriched |
AKR1C2 | Aldo-keto reductase family 1, member C2 | Disease related genes Enzymes FDA approved drug targets
| | ![](/images_static/na_center.gif) | | ![](/images/47304/103865_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
ALDH6A1 | Aldehyde dehydrogenase 6 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | ![](/images/29074/65842_A_2_6_rna_selected_60x60.jpg) | Group enriched |
AMPH | Amphiphysin | Cancer-related genes
| | | | ![](/images/8559/22541_B_2_8_rna_selected_60x60.jpg) | Tissue enriched |
ANPEP | Alanyl (membrane) aminopeptidase | CD markers Enzymes Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2417/6119_B_9_2_rna_selected_60x60.jpg) | Group enriched |
AQP3 | Aquaporin 3 (Gill blood group) | Blood group antigen proteins Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/14924/33951_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
ASS1 | Argininosuccinate synthase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | ![](/images/20896/48102_B_2_1_rna_selected_60x60.jpg) | Tissue enhanced |
B3GAT1 | Beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) | Enzymes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2500/6207_B_3_3_rna_selected_60x60.jpg) | Tissue enriched |
B4GALNT1 | Beta-1,4-N-acetyl-galactosaminyl transferase 1 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/8968/24762_A_3_3_rna_selected_60x60.jpg) | Tissue enriched |
BAG2 | BCL2-associated athanogene 2 | Plasma proteins
| | | | ![](/images/19918/47053_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
BIN1 | Bridging integrator 1 | Disease related genes
| | | | ![](/images/3894/12744_A_8_3_rna_selected_60x60.jpg) | Tissue enriched |
BTK | Bruton agammaglobulinemia tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | ![](/images/1198/2772_A_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
C1orf116 | Chromosome 1 open reading frame 116 | | | ![](/images_static/na_center.gif) | | ![](/images/11888/28062_B_7_6_rna_selected_60x60.jpg) | Tissue enhanced |
C4BPA | Complement component 4 binding protein, alpha | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/926/2497_B_8_8_rna_selected_60x60.jpg) | Tissue enriched |
CA1 | Carbonic anhydrase I | Enzymes FDA approved drug targets Plasma proteins
| | ![](/images_static/na_center.gif) | | ![](/images/6558/22094_B_9_1_rna_selected_60x60.jpg) | Group enriched |
CA3 | Carbonic anhydrase III, muscle specific | Enzymes FDA approved drug targets Plasma proteins
| | ![](/images_static/na_center.gif) | | ![](/images/21775/48848_B_7_7_rna_selected_60x60.jpg) | Tissue enriched |
CAP2 | CAP, adenylate cyclase-associated protein, 2 (yeast) | Cancer-related genes
| | ![](/images/50530/if_selected_60x60.jpg) | | ![](/images/50530/123834_B_1_7_rna_selected_60x60.jpg) | Tissue enhanced |
CASC5 | Cancer susceptibility candidate 5 | Cancer-related genes Disease related genes Plasma proteins
| | | | ![](/images/26624/56299_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
CAV1 | Caveolin 1, caveolae protein, 22kDa | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | ![](/images/3791/10084_B_5_5_rna_selected_60x60.jpg) | Tissue enhanced |
CBS | Cystathionine-beta-synthase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | ![](/images/1223/5627_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
CCR7 | Chemokine (C-C motif) receptor 7 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/3796/11202_A_9_6_rna_selected_60x60.jpg) | Group enriched |
CCSAP | Centriole, cilia and spindle-associated protein | | | ![](/images/28402/if_selected_60x60.jpg) | | ![](/images/43443/129085_B_8_7_rna_selected_60x60.jpg) | Tissue enhanced |
CD247 | CD247 molecule | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/8750/27531_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
CD27 | CD27 molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2420/6095_A_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
CD3E | CD3e molecule, epsilon (CD3-TCR complex) | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/43955/119468_A_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
CD48 | CD48 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2497/6307_A_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
CD6 | CD6 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | ![](/images/2489/if_selected_60x60.jpg) | | ![](/images/2489/6143_B_7_2_rna_selected_60x60.jpg) | Tissue enhanced |
CD69 | CD69 molecule | CD markers Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2503/6465_A_8_7_rna_selected_60x60.jpg) | Tissue enhanced |
CDH15 | Cadherin 15, type 1, M-cadherin (myotubule) | Disease related genes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/9139/26255_B_9_2_rna_selected_60x60.jpg) | Tissue enriched |
CDH2 | Cadherin 2, type 1, N-cadherin (neuronal) | CD markers Plasma proteins Predicted membrane proteins
| | | | ![](/images/58574/142433_B_8_7_rna_selected_60x60.jpg) | Tissue enhanced |
CDX2 | Caudal type homeobox 2 | Cancer-related genes Transcription factors
| | | | ![](/images/2221/5839_B_9_3_rna_selected_60x60.jpg) | Group enriched |
CEACAM5 | Carcinoembryonic antigen-related cell adhesion molecule 5 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/21/18_B_7_1_rna_selected_60x60.jpg) | Group enriched |
CHGA | Chromogranin A (parathyroid secretory protein 1) | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | ![](/images/17369/if_selected_60x60.jpg) | | ![](/images/17369/141312_A_1_1_rna_selected_60x60.jpg) | Tissue enhanced |
CLDN16 | Claudin 16 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | | ![](/images/56020/144938_B_2_1_rna_selected_60x60.jpg) | Tissue enriched |
CMTM5 | CKLF-like MARVEL transmembrane domain containing 5 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/52338/123160_A_4_4_rna_selected_60x60.jpg) | Tissue enriched |
CNDP1 | Carnosine dipeptidase 1 (metallopeptidase M20 family) | Enzymes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/8933/24067_A_4_5_rna_selected_60x60.jpg) | Group enriched |
COL4A2 | Collagen, type IV, alpha 2 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | ![](/images/10751/28520_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
COLEC12 | Collectin sub-family member 12 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/47917/109321_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
CSTA | Cystatin A (stefin A) | Cancer-related genes Disease related genes Plasma proteins
| | | | ![](/images/469/2664_B_6_6_rna_selected_60x60.jpg) | Tissue enhanced |
CTAG1A | Cancer/testis antigen 1A | Cancer-related genes
| | ![](/images_static/na_center.gif) | | ![](/images/13061/32111_A_2_4_rna_selected_60x60.jpg) | Tissue enriched |
CTSG | Cathepsin G | Enzymes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/47737/123206_B_8_8_rna_selected_60x60.jpg) | Tissue enriched |
DCT | Dopachrome tautomerase | Enzymes Predicted membrane proteins
| | | | ![](/images/10743/26204_B_6_7_rna_selected_60x60.jpg) | Tissue enriched |
DUSP9 | Dual specificity phosphatase 9 | Enzymes
| | ![](/images_static/na_center.gif) | | ![](/images/3336/9545_B_9_2_rna_selected_60x60.jpg) | Group enriched |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | ![](/images/18530/41188_B_6_4_rna_selected_60x60.jpg) | Tissue enhanced |
ESR1 | Estrogen receptor 1 | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Transcription factors
| | ![](/images_static/na_center.gif) | | ![](/images/37/267_B_7_5_rna_selected_60x60.jpg) | Tissue enhanced |